Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/12100
Title: Fresh, equilibrated and post-thaw sperm quality of piracanjuba brycon orbignyanus and streaked prochilod prochilodus lineatus males treated with either salmon gnrha and domperidone or pituitary extract
Keywords: Computer-assisted sperm analyzer
Characiformes
Cryopreservation
Ovaprim™
Sperm motility
Issue Date: 2015
Publisher: Sociedade Brasileira de Ictiologia
Citation: VIVEIROS, A. T. de M. et al. Fresh, equilibrated and post-thaw sperm quality of piracanjuba brycon orbignyanus and streaked prochilod prochilodus lineatus males treated with either salmon gnrha and domperidone or pituitary extract. Neotropical Ichthyology, Porto Alegre, v. 13, n. 1, p. 157-164, 2015.
Abstract: The effects of reduced doses of Ovaprim™ (GnRHa + domperidone) on sperm release of Brycon orbignyanus and Prochilodus lineatus were evaluated. Furthermore, sperm quality was compared among fresh, equilibrated and postthaw samples. Males received a single and reduced dose of Ovaprim™ (0.125 or 0.25 ml/kg); control males received pituitary extract (cPE; 3 mg/kg). Fresh sperm was evaluated for volume, concentration, seminal plasma osmolality and seminal plasma pH. Then sperm was diluted in a freezing medium, equilibrated for 15-20 min and frozen in nitrogen vapor vessel (dry-shipper). Sperm motility was analyzed during 60 s post-activation in fresh, equilibrated and post-thaw samples. Sperm quality of males treated with Ovaprim™ (both doses) were not different from that of cPE-treated males, thus these data were pooled. In B. orbignyanus, motility was higher in fresh (99%) than in equilibrated sperm (81%); post-thaw motility dropped to 42%. In P. lineatus, motility was similar in fresh (99%) and equilibrated sperm (92%); post-thaw motility was 73%. Motility decreased as a function of time post-activation, and this decrease was significant after 60 s in fresh and equilibrated sperm, and as soon as 30 s in post-thaw sperm, in both species. Ovaprim™ at ¼ of the recommended dose can successfully replace cPE.
URI: http://repositorio.ufla.br/jspui/handle/1/12100
http://www.scielo.br/pdf/ni/v13n1/1679-6225-ni-20140066.pdf
Appears in Collections:DZO - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.